Pharma News
Novo Nordisk Acquires Cardior Pharmaceuticals for $1.112B in Effort to Bolster Cardiovascular Disease Pipeline
![](https://meefro.com/wp-content/uploads/2024/03/Novo-Nordisk-Acquires-Cardior-Pharmaceuticals-for-1112B-in-Effort-to-780x470.png)
Deal includes the novel treatment CDR132L, which is currently in Phase II clinical trials for heart failure.
Source link
#Novo #Nordisk #Acquires #Cardior #Pharmaceuticals #1.112B #Effort #Bolster #Cardiovascular #Disease #Pipeline